Skip to main content
. 2022 Feb 23;16:101176. doi: 10.1016/j.bonr.2022.101176

Table 2.

Description of pathogenic variant, p.(Val667Met) LRP5 variant and variant of unknown significance.

Gene cDNA Protein Gender Age at first fracture (years) Age at diagnosis (years) Peripheral fractures Vertebral fractures LS-BMD (Z-score) Other diseases
Pathogenic variant
1 ALPL c.77C > T p.(Pro26Leu) F 28.0 28.0 Ribs, metacarpal Yes −2.8
2 COL1A1 c.2792C > A p.(Ala931Asp) F 32.0 50.0 Yes Yes −3.4
3 COL1A2 c.577G > A p.(Gly193Ser) M 7.0 7.2 No Yes −2.4
4 COL1A2 c.3305G > C p.(Gly1102Ala) F 2.0 7.9 Radius-ulna, humerus No −2.0
5 COL1A2a c.2821C > A p.(Gln941Lys) M 10.0 28.0 No Yes −2.4 Auto-immune thyroiditis, prolactin adenoma
6 COL1A2 c.1666G > A p.(Gly556Ser) F 47.0 47.0 No Yes −4.5
7 COL1A2 c.946G > A p.(Gly316Ser) F ND 52.0 No Yes −4.3 Uveitis, otospongiosis, ankylosing spondylitis HLAB27-
8 DKK1b c.359G > T p.Arg120Leu F ND 53.0 Radius, metatarsal No −3.4
9 LRP5 c.1425G > A p.(Trp475*) F 5.0 5.9 Radius-ulna No −0.7
10 LRP5 c.2225 T > G p.(Ile742Ser) M 3.0 8.8 Tibia, femur, radius No −3.4
11 LRP5a c.2273G > A p.(Arg758Lys) M ND 13.5 Wrist, ankle No −1.9 Spondylolisthesis L5-S1
12 LRP5 c.4105_4106delAT p.(Met1369Valfs*2) F 47.0 47.0 Pelvis No −4.9 Auto-immune thyroiditis
13 LRP5 c.4502C > T p.(Pro1501Leu) F ND 60.0 Metatarsal Yes −3.7
14 LRP5 c.1393G > A p.(Ala465Thr) M 48.0 65.0 No Yes −2.3
15 WNT1c c.711_726del p.(Thr238Alafs*150) M 7.0 7.3 Femur No −3.7 Charcot-Marie-tooth disease with normal mobility
16 WNT1 c.403delG p.Val135SerfsTer64 M 7.0 8.4 Wrist, femur, fibula Yes −2.3 Moderate asthma without treatment
17 WNT1 c.962C > T p.(Ala321Val) F 10.0 8.9 Yes −1.3 Beta thalassemia
18 WNT1 c.610G > T p.(Glu204*) M 52.0 44.0 Yes −3.0



p.(Val667Met) LRP5 variant
19 LRP5 c.1999G > A p.(Val667Met) F 7.0 10.7 Radius-cubitus, radius, femur No −2.8 Learning difficulties, albinism
20 LRP5 c.1999G > A p.(Val667Met) F ND 11.9 No Yes −2.4 Learning difficulties
21 LRP5 c.1999G > A p.(Val667Met) F 31.0 31.0 Yes Yes −2.9
22 LRP5 c.1999G > A p.(Val667Met) F 16.0 35.0 Femur No −2.5 Migraine
23 LRP5 c.1999G > A p.(Val667Met) M 15.0 50.0 Tibia, elbow, clavicula, ribs, phalanges No −2.0 Breast cancer, mild form of inflammatory rheumatic disorders
24 LRP5 c.1999G > A p.(Val667Met) M 42.0 53.0 No Yes −4.3
25 LRP5 c.1999G > A p.(Val667Met) F 54.0 54.0 Femur No −2.7



Variant of unknown significance
26 COL1A1 c.1875 + 3G > T p.(?) F 20.0 Femur −2.1
27 FKBP10 c.926G > A p.(Arg309His) F 42.0 42.0 Ribs No −4.7
28 LRP5 c.3977G > A p.(Arg1326His) F ND 46.0 No No −3.4 Mild form of rheumatoid arthritis
29 RANK c.718A > G p.(Lys240Glu) F 2.0 9.8 Wrist, radius, femur, radius No −2.1 Moderate asthma without treatment, pyelonephritis
30 RANK c.1660A > G p.(Thr554Ala) M 7.0 11.9 Elbow, radius No −2.0 Horseshoe kidney
31 RANK c.544G > A p.(Val1182Ile) M ND 41.0 No Yes −3.4
32 WNT1 c.1013C > T p.(Thr338Met) M 15.0 15.9 Tibia No −2.4 Algodystrophy
33 WNT1 c.793C > A p.(Arg265Ser) F 52.0 52.0 Ribs No −4.0 Breast cancer, low-grade chondrosarcoma

LS-BMD: lumbar spine BMD; ND: non-determined; VUS: variant of unknown significance.

a

Associated with a p.(Val667Met) LRP5 variant.

b

Associated with a VUS in ALPL gene (c.1574delG, p.(Ter525=)).

c

Associated with a VUS in OPG gene (c.1012G > A, p.(Asp338Asn)).